TuHURA Biosciences Shares Outstanding History (HURA)
TuHURA Biosciences reported 59.3M shares outstanding at the end of fiscal 2025.
View full TuHURA Biosciences company overviewTuHURA Biosciences annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 59.3M | 47.2M | +387.65% |
| 2024 · Dec 31 | 2024-12-31 | 12.2M | −7.4M | −37.71% |
| 2019 | 2019-06-30 | 19.5M | −3.3M | −14.40% |
| 2018 | 2018-06-30 | 22.8M | −222.9M | −90.71% |
| 2017 | 2017-06-30 | 245.7M | −7.8M | −3.08% |
| 2016 | 2016-06-30 | 253.5M | −12.5M | −4.70% |
| 2015 | 2015-06-30 | 266.0M | −8.73B | −97.04% |
| 2014 | 2014-06-30 | 9.00B | 1.11B | +14.14% |
| 2013 | 2013-12-31 | 7.88B | 6.90B | +699.56% |
| 2012 | 2012-06-30 | 986.0M | −501.5M | −33.71% |
| 2011 · Jun 30 | 2011-06-30 | 1.49B | — | — |
TuHURA Biosciences quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 63.7M | 13.8M | +27.58% |
| Q1 2026 | 2026-03-31 | 63.6M | 19.9M | +45.55% |
| Q4 2025 | 2025-12-31 | 59.3M | 17.0M | +40.20% |
| Q3 2025 | 2025-09-30 | 51.3M | 31.7M | +162.41% |
| Q2 2025 | 2025-06-30 | 49.9M | −90.8M | −64.52% |
| Q1 2025 · Mar 31 | 2025-03-31 | 43.7M | −97.0M | −68.95% |
| Q4 2024 · Dec 31 | 2024-12-31 | 42.3M | −98.4M | −69.92% |
| Q4 2019 | 2019-06-30 | 19.5M | −208.7M | −91.44% |
| Q3 2019 | 2019-03-31 | 140.7M | −92.5M | −39.67% |
| Q2 2019 | 2018-12-31 | 140.7M | −92.5M | −39.67% |
| Q1 2019 | 2018-09-30 | 140.7M | −105.0M | −42.74% |
| Q4 2018 | 2018-06-30 | 228.2M | −2.57B | −91.84% |
| Q3 2018 | 2018-03-31 | 233.2M | −2.61B | −91.80% |
| Q2 2018 | 2017-12-31 | 233.2M | −2.61B | −91.80% |
| Q4 2017 | 2017-06-30 | 245.7M | −2.55B | −91.22% |
| Q3 2017 | 2017-03-31 | 2.80B | 2.53B | +951.40% |
| Q2 2017 | 2016-12-31 | 2.85B | −7.02B | −71.15% |
| Q1 2017 | 2016-09-30 | 2.85B | −6.80B | −70.50% |
| Q4 2016 | 2016-06-30 | 2.80B | −6.41B | −69.64% |
| Q4 2015 | 2015-06-30 | 266.0M | −8.73B | −97.04% |
| Q3 2015 | 2015-03-31 | 9.86B | 1.84B | +22.98% |
| Q2 2015 | 2014-12-31 | 9.65B | 1.76B | +22.34% |
| Q1 2015 | 2014-09-30 | 9.21B | 1.33B | +16.89% |
| Q4 2014 | 2014-06-30 | 9.00B | 1.21B | +15.55% |
| Q1 2014 | 2014-03-31 | 8.02B | 361.8M | +4.72% |
| Q4 2013 | 2013-12-31 | 7.88B | 6.80B | +626.54% |
| Q3 2013 · Sep 30 | 2013-09-30 | 7.88B | 4.62B | +141.53% |
| Q2 2013 · Jun 30 | 2013-06-30 | 7.79B | 6.80B | +689.81% |
| Q3 2013 · Mar 31 | 2013-03-31 | 7.66B | 6.67B | +676.75% |
| Q2 2013 · Jan 25 | 2013-01-25 | 1.09B | −402.4M | −27.05% |
| Q2 2013 · Dec 31 | 2012-12-31 | 3.26B | — | — |
| Q1 2013 | 2012-09-30 | 986.0M | — | — |
| Q4 2012 | 2012-06-30 | 986.0M | — | — |
| Q4 2011 · Jun 30 | 2011-06-30 | 1.49B | — | — |
TuHURA Biosciences shares outstanding trends
Over the last five reported fiscal years, TuHURA Biosciences's shares outstanding moved from 253.5M to 59.3M, a change of −194.2M. The latest reported quarter, Q2 2026, shows 63.7M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TuHURA Biosciences filings at SEC.gov ↗